V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280006392 | 280003919 | null | 70.2 | Disease modification (D) | 2013-02-14 | 2013-02-21 | GEMCARBO | N | N | 280030805 | CARBO + FLUOROURACIL |
| 280006393 | 280003919 | 1.56 | 59.3 | Curative (C) | 2014-10-13 | 2014-10-16 | Cisplatin + Fluorouracil + RT 5day | N | null | 280030805 | CISPLATIN + FLUOROURACIL + RT |
| 280006394 | 280003919 | 1.64 | null | Palliative (P) | 2016-03-08 | 2016-03-08 | PEMBROLIZUMAB | N | N | 280030805 | DOCETAXEL |
| 280006395 | 280003919 | null | null | null | 2014-03-03 | 2014-03-03 | Epirubicin | 2 | N | 280030805 | CISPLATIN + FLUOROURACIL + RT |
| 280006396 | 280003919 | 1.7 | null | Neo-adjuvant (N) | 2013-05-03 | 2013-05-06 | Cisplatin + Docetaxel | N | N | 280030805 | BCG |
| 280006397 | 280003920 | 1.83 | 68.6 | Curative (C) | 2015-09-27 | 2015-10-01 | Cisplatin + Fluorouracil + RT 5day | 02 | null | 280030812 | CISPLATIN + FLUOROURACIL + RT |
| 280006398 | 280003921 | 1.64 | 52 | Not known (9) | 2015-05-19 | 2015-05-19 | Irinotecan + Modified De Gramont | N | N | 280030813 | DHAP |
| 280006399 | 280003922 | 1.7 | 73.9 | Palliative (P) | 2016-11-08 | 2016-11-21 | Capecitabine (14 days)+Carboplatin | N | N | 280030815 | GEMCITABINE |
| 280006400 | 280003923 | null | 88.35 | Palliative (P) | 2014-03-11 | 2014-03-15 | Cisplatin + Doxorubicin | N | N | 280030816 | DOXORUBICIN + OLARATUMAB |
| 280006401 | 280003924 | 1.76 | null | Adjuvant (A) | 2013-03-12 | 2013-03-13 | Capecitabine | Y | N | 280030817 | CARBOPLATIN + VINORELBINE |
| 280006402 | 280003925 | 1.63 | 45 | Palliative (P) | 2016-01-26 | 2016-03-05 | EW EuroEwing 2012 Arm A VIDE | N | N | 280030821 | CETUXIMAB + CISPLATIN + FU |
| 280006403 | 280008137 | 1.61 | null | Palliative (P) | 2016-06-28 | 2016-07-18 | Oxaliplatin + Modified de Gramont | N | N | 280030822 | CARBOPLATIN + LIPOSOMAL DOX |
| 280006404 | 280003926 | 1.86 | 59.6 | Curative (C) | 2015-10-18 | 2015-11-20 | Capecitabine | null | N | 280030823 | COMPARE TRIAL |
| 280006405 | 280008138 | 1.61 | 77.6 | Adjuvant (A) | 2017-05-07 | 2017-05-14 | EW EuroEwing 99 : VIDE | Y | Y | 280030825 | CISPLATIN + VINORELBINE |
| 280006406 | 280008138 | 1.89 | 65.2 | Palliative (P) | 2013-07-07 | 2013-07-16 | Trabectedin | N | N | 280030825 | DOCETAXEL + GEMCITABINE |
| 280006407 | 280003927 | 1.65 | 60.7 | Curative (C) | 2014-05-06 | 2014-05-07 | CAPECITABINE + OXALIPLATIN | N | N | 280030827 | BEAM |
| 280006408 | 280008139 | 1.81 | 89.1 | Neo-adjuvant (N) | 2016-07-29 | 2016-07-30 | Mitomycin Intravesical | N | Y | 280030828 | RMS 2005 TRIAL |
| 280006409 | 280008139 | 1.79 | 76.6 | null | 2014-08-17 | 2014-05-18 | GemCarbo Days 1+8 | null | null | 280030828 | VINORELBINE |
| 280006410 | 280003928 | 1.76 | 66.2 | Curative (C) | 2017-02-01 | 2017-02-01 | Capecitabine + Cisplatin | 02 | N | 280030830 | DE-ESCALATE TRIAL |
| 280006411 | 280003929 | null | 62.4 | Palliative (P) | 2018-05-27 | 2018-06-14 | PEMBROLIZUMAB | N | N | 280030835 | TRABECTEDIN |
| 280006412 | 280003930 | 1.82 | null | Palliative (P) | 2015-05-27 | 2015-05-28 | ECX | N | N | 280030836 | LIPOSOMAL DOXORUBICIN |
| 280006413 | 280003931 | null | 69.35 | Neo-adjuvant (N) | 2017-06-15 | 2017-06-18 | CAPECITABINE + IRINOTECAN | N | N | 280030837 | CARBO + FLUOROURACIL |
| 280006414 | 280003932 | 1.72 | 55 | Curative (C) | 2013-02-01 | 2013-02-03 | Doxorubicin + Olaratumab | 01 | N | 280030838 | CHOP R |
| 280006415 | 280003932 | 1.8 | 75.9 | Neo-adjuvant (N) | 2016-04-22 | 2016-05-20 | Capecitabine | 02 | N | 280030838 | VIDE |
| 280006416 | 280003933 | 1.7 | null | Palliative (P) | 2015-03-24 | 2015-04-08 | IVA | N | N | 280003734 | GEMCARBO |
| 280006417 | 280003934 | 1.72 | 94.8 | Palliative (P) | 2018-10-29 | 2018-11-17 | VDC | N | N | 280004679 | TRABECTEDIN |
| 280006418 | 280003934 | null | 83.6 | Curative (C) | null | 2016-07-26 | LANREOTIDE | N | N | 280004679 | IVA |
| 280006419 | 280003935 | null | null | Palliative (P) | 2017-01-14 | 2017-01-17 | Oxaliplatin + Modified de Gramont | N | N | 280008807 | DOXORUBICIN + OLARATUMAB |
| 280006420 | 280008142 | 1.77 | 81.1 | Curative (C) | 2016-12-30 | 2017-01-06 | STS Rhabdomyosarcoma RMS 2005 IVA | N | N | 280009079 | COMPARE TRIAL |
| 280006421 | 280003936 | null | null | Palliative (P) | 2016-06-30 | 2016-07-12 | Pazopanib | N | N | 280009938 | CAPECITABINE + CARBOPLATIN |
| 280006422 | 280003937 | 1.82 | 54 | Palliative (P) | 2018-09-13 | 2018-09-13 | Trabectedin | 02 | N | 280010958 | IFOSFAMIDE |
| 280006423 | 280003938 | null | null | Palliative (P) | 2016-09-05 | 2016-09-08 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | 280012919 | DACARBAZINE + GEMCITABINE |
| 280006424 | 280003938 | 1.8 | 82.2 | Palliative (P) | 2018-07-08 | 2018-07-13 | IVA | 01 | N | 280012919 | BORTEZOMIB |
| 280006425 | 280003938 | 1.95 | 0 | Curative (C) | null | 2014-03-20 | IVADo | N | N | 280012919 | BEAM |
| 280006426 | 280003939 | null | null | null | null | 2014-03-10 | Capecitabine + Oxaliplatin 14day | null | null | 280014217 | PAZOPANIB |
| 280006427 | 280003940 | 1.73 | null | Adjuvant (A) | 2016-01-12 | 2016-01-20 | DA 3+8 | null | N | 280014344 | CAPECITABINE |
| 280006428 | 280008144 | null | 66.3 | Palliative (P) | 2018-01-29 | 2018-01-29 | PACLITAXEL | N | N | 280014550 | CISPLATIN + FLUOROURACIL + RT |
| 280006429 | 280003941 | null | 59 | Palliative (P) | 2017-07-01 | 2017-07-01 | Carboplatin + Pemetrexed | 02 | N | 280015738 | MAP |
| 280006430 | 280003941 | null | 0 | null | 2018-06-28 | 2018-06-28 | VIDE | N | N | 280015738 | IVADO |
| 280006431 | 280003942 | null | 0 | Curative (C) | 2016-10-30 | 2016-10-30 | EW EuroEwing 99 : VIDE | N | null | 280016361 | VIDE |
| 280006432 | 280003943 | null | -1 | Palliative (P) | null | 2017-04-21 | VINCRISTINE | Y | null | 280016364 | DOXORUBICIN + OLARATUMAB |
| 280006433 | 280003944 | 1.62 | 79.7 | Palliative (P) | 2014-06-06 | 2014-06-15 | Gemcitabine 1000mg/m2 D1 8 15 | 2 | N | 280016493 | DOCETAXEL + GEMCITABINE |
| 280006434 | 280003945 | 1.72 | 68 | Palliative (P) | 2018-04-28 | 2018-04-28 | VIDE | 2 | N | 280016663 | GEMCARBO |
| 280006435 | 280003946 | null | 2 | Palliative (P) | null | 2018-04-03 | IVA | null | null | 280017475 | PEMBROLIZUMAB |
| 280006436 | 280003946 | null | 50.7 | null | 2017-05-18 | 2017-05-18 | CYCLOPHOSPHAMIDE | N | Y | 280017475 | TIMELY TRIAL |
| 280006437 | 280003947 | null | 110 | null | 2016-12-12 | 2017-01-11 | NIVOLUMAB | N | N | 280017961 | IFOSFAMIDE |
| 280006438 | 280003948 | 1.75 | 93.6 | Curative (C) | 2015-03-04 | 2015-03-06 | CARBOPLATIN + FLUOROURACIL | Y | Y | 280017963 | DE-ESCALATE TRIAL |
| 280006439 | 280003949 | 1.98 | 71.5 | null | null | 2014-10-09 | CVP R | Y | null | 280018042 | FLUOROURACIL + MITOMYCIN + RT |
| 280006440 | 280003949 | 1.54 | 57.6 | Curative (C) | 2013-03-28 | 2013-04-08 | Cisplatin + Vinorelbine (IV) | N | null | 280018042 | CISPLATIN + FLUOROURACIL + RT |
| 280006441 | 280003949 | 1.64 | 52.2 | Palliative (P) | 2016-01-17 | 2016-01-18 | Trabectedin | 02 | N | 280018042 | CAPECITABINE + CARBOPLATIN |